Growth Suppression by Acute PromyelocyticLeukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression

REFERENCES

• Albert, T., J. Wells, J. O. Funk, A. Pullner, E. E. Raschke, G. Stelzer, M. Meisterernst, P. J. Farnham, and D. Eick. 2001. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J. Biol. Chem. 276: 20482–20490.
   PubMedGoogle Scholar
• Alizadeh, A., M. Eisen, R. E. Davis, C. Ma, H. Sabet, T. Tran, J. I. Powell, L. Yang, G. E. Marti, D. T. Moore, J. R. Hudson, Jr., W. C. Chan, T. Greiner, D. Weisenburger, J. O. Armitage, I. Lossos, R. Levy, D. Botstein, P. O. Brown, and L. M. Staudt. 1999. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symp. Quant. Biol. 64: 71–78.
   PubMedGoogle Scholar
• Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, Jr., L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, R. Levy, W. Wilson, M. R. Grever, J. C. Byrd, D. Botstein, P. O. Brown, and L. M. Staudt. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503–511.
   PubMed Web of Science ®Google Scholar
• Ball, H. J., A. Melnick, R. Shaknovich, R. A. Kohanski, and J. D. Licht. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res. 27: 4106–4113.
   PubMedGoogle Scholar
• Barna, M., N. Hawe, L. Niswander, and P. P. Pandolfi. 2000. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25: 166–172.
   PubMed Web of Science ®Google Scholar
• Barrett, T. J., N. P. Sandhu, A. J. Tomlinson, L. M. Benson, M. Subramaniam, S. Naylor, and T. C. Spelsberg. 2000. Interactions of the nuclear matrix-associated steroid receptor binding factor with its DNA binding element in the c-myc gene promoter. Biochemistry 39: 753–762.
   PubMedGoogle Scholar
• Bartley, P. A., J. K. Lutwyche, and T. J. Gonda. 2001. Identification and validation of candidate Myb target genes. Blood Cells Mol. Dis. 27: 409–415.
   Google Scholar
• Batanian, J. R., E. Ma, Y. Huang, and B. Gadre. 2001. Co-existence of alternative forms of 8q gain in cytogenetic clones of three patients with acute myeloid leukemia, pointing to 8q22 approximately 8qter as a region of biologic significance. Cancer Genet. Cytogenet. 126: 20–25.
   PubMedGoogle Scholar
• Boer, J., J. Bonten-Surtel, and G. Grosveld. 1998. Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol. Cell. Biol. 18: 1236–1247.
   PubMedGoogle Scholar
• Bruckert, P., R. Kappler, H. Scherthan, H. Link, F. Hagmann, and H. Zankl. 2000. Double minutes and c-MYC amplification in acute myelogenous leukemia: are they prognostic factors? Cancer Genet. Cytogenet. 120: 73–79.
   PubMed Web of Science ®Google Scholar
• Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent. 1993. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12: 1161–1167.
   PubMed Web of Science ®Google Scholar
• Chernukhin, I. V., S. Shamsuddin, A. F. Robinson, A. F. Carne, A. Paul, A. I. El-Kady, V. V. Lobanenkov, and E. M. Klenova. 2000. Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J. Biol. Chem. 275: 29915–29921.
   PubMedGoogle Scholar
• Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P.-Y. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13: 2858–2869.
   PubMed Web of Science ®Google Scholar
• Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18: 2916–2924.
   PubMed Web of Science ®Google Scholar
• Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97: 3260–3265.
   PubMed Web of Science ®Google Scholar
• Cook, M., A. Gould, N. Brand, J. Davies, P. Strutt, R. Shaknovich, J. Licht, S. Waxman, Z. Chen, S. Gluecksohn-Waelsch, et al. 1995. Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. Proc. Natl. Acad. Sci. USA 92: 2249–2253.
   PubMedGoogle Scholar
• Dai, M. S., N. Chevallier, S. Stone, M. C. Heinrich, M. McConnell, T. Reuter, H. E. Broxmeyer, J. D. Licht, L. Lu, and M. E. Hoatlin. 2002. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. J. Biol. Chem. 277: 26327–26334.
   PubMedGoogle Scholar
• Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19: 1–11.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., L. M. Resar, E. Emison, S. Kim, Q. Li, J. E. Prescott, D. Wonsey, and K. Zeller. 1999. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253: 63–77.
   PubMed Web of Science ®Google Scholar
• David, G., L. Alland, S. H. Hong, C. W. Wong, R. A. DePinho, and A. Dejean. 1998. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16: 2549–2556.
   PubMed Web of Science ®Google Scholar
• Di Croce, L., V. A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F. Lo Coco, T. Kouzarides, C. Nervi, S. Minucci, and P. G. Pelicci. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079–1082.
   PubMed Web of Science ®Google Scholar
• Facchini, L. M., S. Chen, W. W. Marhin, J. N. Lear, and L. Z. Penn. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17: 100–114.
   PubMed Web of Science ®Google Scholar
• Feo, S., D. Arcuri, E. Piddini, R. Passantino, and A. Giallongo. 2000. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 473: 47–52.
   PubMed Web of Science ®Google Scholar
• Freemantle, S. J., J. S. Kerley, S. L. Olsen, R. H. Gross, and M. J. Spinella. 2002. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21: 2880–2889.
   PubMedGoogle Scholar
• Gartel, A. L., X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner. 2001. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. USA 98: 4510–4515.
   PubMed Web of Science ®Google Scholar
• Ghosh, A. K., I. Grigorieva, R. Steele, R. G. Hoover, and R. B. Ray. 1999. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene 235: 85–91.
   PubMedGoogle Scholar
• Grigorieva, I., V. G. Grigoriev, M. K. Rowney, and R. G. Hoover. 2000. Regulation of c-myc transcription by interleukin-2 (IL-2): identification of a novel IL-2 response element interacting with STAT-4. J. Biol. Chem. 275: 7343–7350.
   PubMedGoogle Scholar
• Grimwade, D., H. Walker, F. Oliver, K. Wheatley, C. Harrison, G. Harrison, J. Rees, I. Hann, R. Stevens, A. Burnett, and A. Goldstone. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92: 2322–2333.
   PubMed Web of Science ®Google Scholar
• Guo, Q. M., R. L. Malek, S. Kim, C. Chiao, M. He, M. Ruffy, K. Sanka, N. H. Lee, C. V. Dang, and E. T. Liu. 2000. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res. 60: 5922–5928.
   PubMed Web of Science ®Google Scholar
• He, L., J. Liu, I. Collins, S. Sanford, B. O'Connell, C. J. Benham, and D. Levens. 2000. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 19: 1034–1044.
   PubMed Web of Science ®Google Scholar
• He, L. Z., M. Bhaumik, C. Tribioli, E. M. Rego, S. Ivins, A. Zelent, and P. P. Pandolfi. 2000. Two critical hits for promyelocytic leukemia. Mol. Cell 6: 1131–1141.
   PubMed Web of Science ®Google Scholar
• He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
   PubMed Web of Science ®Google Scholar
• Hoffman, B., A. Amanullah, M. Shafarenko, and D. A. Liebermann. 2002. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21: 3414–3421.
   PubMed Web of Science ®Google Scholar
• Hoffman, B., and D. A. Liebermann. 1998. The proto-oncogene c-myc and apoptosis. Oncogene 17: 3351–3357.
   PubMed Web of Science ®Google Scholar
• Hummel, J. L., T. Zhang, R. A. Wells, and S. Kamel-Reid. 2002. The retinoic acid receptor alpha (RARα) chimeric proteins PML-, PLZF-, NPM-, and NuMA-RARα have distinct intracellular localization patterns. Cell Growth Differ. 13: 173–183.
   PubMedGoogle Scholar
• Itkes, A., C. J. Allegra, and M. Zajac-Kaye. 2000. Multiprotein complexes present at the MIF motifs flanking the promoter of the human c-myc gene. FEBS Lett. 474: 23–28.
   PubMedGoogle Scholar
• Johansen, L. M., A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen. 2001. c-Myc is a critical target for C/EBPα in granulopoiesis. Mol. Cell. Biol. 21: 3789–3806.
   PubMed Web of Science ®Google Scholar
• Kerley, J. S., S. L. Olsen, S. J. Freemantle, and M. J. Spinella. 2001. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285: 969–975.
   PubMedGoogle Scholar
• Labbaye, C., M. T. Quaranta, A. Pagliuca, S. Militi, J. D. Licht, U. Testa, and C. Peschle. 2002. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21: 6669–6679.
   PubMed Web of Science ®Google Scholar
• Lee, K.-H., M.-Y. Chang, J.-I. Ahn, D.-H. Yu, S.-S. Jung, J.-H. Choi, Y.-H. Noh, Y.-S. Lee, and M.-J. Ahn. 2002. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem. Biophys. Res. Commun. 296: 1125–1133.
   PubMed Web of Science ®Google Scholar
• Lee, T. C., and E. B. Ziff. 1999. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. J. Biol. Chem. 274: 595–606.
   PubMed Web of Science ®Google Scholar
• Li, J. Y., M. A. English, H. J. Ball, P. L. Yeyati, S. Waxman, and J. D. Licht. 1997. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 272: 22447–22455.
   PubMedGoogle Scholar
• Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13: 4070–4079.
   PubMedGoogle Scholar
• Licht, J. D., R. Shaknovich, M. A. English, A. Melnick, J. Y. Li, J. C. Reddy, S. Dong, S. J. Chen, A. Zelent, and S. Waxman. 1996. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12: 323–336.
   PubMed Web of Science ®Google Scholar
• Lin, R. J., L. Nagy, S. Inoue, W. Shao, W. H. Miller, Jr., and R. M. Evans. 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811–814.
   PubMed Web of Science ®Google Scholar
• Lin, R. J., T. Sternsdorf, M. Tini, and R. M. Evans. 2001. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20: 7204–7215.
   PubMed Web of Science ®Google Scholar
• Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23: 1686–1690.
   PubMed Web of Science ®Google Scholar
• Liu, M., M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10: 142–153.
   PubMed Web of Science ®Google Scholar
• Lopez-Rodriguez, C., M. D. Delgado, A. Puig-Kroger, A. Nueda, E. Munoz, J. Leon, C. Bernabeu, and A. L. Corbi. 2000. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters. Eur. J. Immunol. 30: 2465–2471.
   PubMedGoogle Scholar
• Melnick, A., K. F. Ahmad, S. Arai, A. Polinger, H. Ball, K. L. Borden, G. W. Carlile, G. G. Prive, and J. D. Licht. 2000. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20: 6550–6567.
   PubMedGoogle Scholar
• Melnick, A., G. Carlile, K. F. Ahmad, C. L. Kiang, C. Corcoran, V. Bardwell, G. G. Prive, and J. D. Licht. 2002. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22: 1804–1818.
   PubMed Web of Science ®Google Scholar
• Melnick, A., and J. D. Licht. 1999. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
   PubMed Web of Science ®Google Scholar
• Melnick, A. M., J. J. Westendorf, A. Polinger, G. W. Carlile, S. Arai, H. J. Ball, B. Lutterbach, S. W. Hiebert, and J. D. Licht. 2000. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 20: 2075–2086.
   PubMed Web of Science ®Google Scholar
• Menssen, A., and H. Hermeking. 2002. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA 99: 6274–6279.
   PubMed Web of Science ®Google Scholar
• Miller, T. L., Y. Jin, J. M. Sun, A. S. Coutts, L. C. Murphy, and J. R. Davie. 1996. Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J. Cell. Biochem. 60: 560–571.
   PubMedGoogle Scholar
• Mitchell, K. O., and W. S. El-Deiry. 1999. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10: 223–230.
   PubMedGoogle Scholar
• Neiman, P. E., A. Ruddell, C. Jasoni, G. Loring, S. J. Thomas, K. A. Brandvold, R. Lee, J. Burnside, and J. Delrow. 2001. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc. Natl. Acad. Sci. USA 98: 6378–6383.
   PubMed Web of Science ®Google Scholar
• Pandolfi, P. P. 2001. In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogene 20: 5726–5735.
   PubMedGoogle Scholar
• Ramana, C. V., N. Grammatikakis, M. Chernov, H. Nguyen, K. C. Goh, B. R. Williams, and G. R. Stark. 2000. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways. EMBO J. 19: 263–272.
   PubMedGoogle Scholar
• Redner, R. L. 2002. Variations on a theme: the alternate translocations in APL. Leukemia 16: 1927–1932.
   PubMed Web of Science ®Google Scholar
• Reid, A., A. Gould, N. Brand, M. Cook, P. Strutt, J. Li, J. Licht, S. Waxman, R. Krumlauf, and A. Zelent. 1995. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86: 4544–4552.
   PubMedGoogle Scholar
• Rusiniak, M. E., M. Yu, D. T. Ross, E. C. Tolhurst, and J. L. Slack. 2000. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Cancer Res. 60: 1824–1829.
   PubMed Web of Science ®Google Scholar
• Sakatsume, O., H. Tsutsui, Y. Wang, H. Gao, X. Tang, T. Yamauchi, T. Murata, K. Itakura, and K. K. Yokoyama. 1996. Binding of THZif-1, a MAZ-like zinc finger protein, to the nuclease-hypersensitive element in the promoter region of the c-MYC protooncogene. J. Biol. Chem. 271: 31322–31333.
   PubMedGoogle Scholar
• Schmidt, M., V. Nazarov, L. Stevens, R. Watson, and L. Wolff. 2000. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol. Cell. Biol. 20: 1970–1981.
   PubMed Web of Science ®Google Scholar
• Schuldiner, O., and N. Benvenisty. 2001. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20: 4984–4994.
   PubMedGoogle Scholar
• Sessarego, M., G. Fugazza, E. Balleari, R. Bruzzone, A. Ballestrero, and F. Patrone. 1997. High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. Cancer Genet. Cytogenet. 97: 161–164.
   PubMedGoogle Scholar
• Shaknovich, R., P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht. 1998. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol. Cell. Biol. 18: 5533–5545.
   PubMedGoogle Scholar
• Simonsson, T., M. Pribylova, and M. Vorlickova. 2000. A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures. Biochem. Biophys. Res. Commun. 278: 158–166.
   PubMed Web of Science ®Google Scholar
• Spinella, M. J., J. S. Kerley, K. A. White, and J. C. Curtin. 2003. Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. J. Nutr. 133: 273S–276S.
   PubMedGoogle Scholar
• Truckenmiller, M. E., M. P. Vawter, C. Cheadle, M. Coggiano, D. M. Donovan, W. J. Freed, and K. G. Becker. 2001. Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor. Neurol. Neurosci. 18: 67–80.
   PubMed Web of Science ®Google Scholar
• Vial, J. P., F. X. Mahon, A. Pigneux, A. Notz, F. Lacombe, J. Reiffers, and C. Bilhou-Nabera. 2003. Derivative (7)t(7;8)(q34;q21), a new additional cytogenetic abnormality in acute promyelocytic leukemia. Cancer Genet Cytogenet. 140: 78–81.
   PubMedGoogle Scholar
• Vindigni, A., A. Ochem, G. Triolo, and A. Falaschi. 2001. Identification of human DNA helicase V with the far upstream element-binding protein. Nucleic Acids Res. 29: 1061–1067.
   PubMedGoogle Scholar
• Ward, J. O., M. J. McConnell, G. W. Carlile, P. P. Pandolfi, J. D. Licht, and L. P. Freedman. 2001. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor. Blood 98: 3290–3300.
   PubMed Web of Science ®Google Scholar
• Watson, J. D., S. K. Oster, M. Shago, F. Khosravi, and L. Z. Penn. 2002. Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277: 36921–36930.
   PubMed Web of Science ®Google Scholar
• Wu, S., C. Cetinkaya, M. J. Munoz-Alonso, N. Von Der Lehr, F. Bahram, V. Beuger, M. Eilers, J. Leon, and L. G. Larsson. 2003. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351–360.
   PubMed Web of Science ®Google Scholar
• Yagi, K., M. Furuhashi, H. Aoki, D. Goto, H. Kuwano, K. Sugamura, K. Miyazono, and M. Kato. 2002. c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277: 854–861.
   PubMed Web of Science ®Google Scholar
• Yeyati, P. L., R. Shaknovich, S. Boterashvili, J. Li, H. J. Ball, S. Waxman, K. Nason-Burchenal, E. Dmitrovsky, A. Zelent, and J. D. Licht. 1999. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18: 925–934.
   PubMed Web of Science ®Google Scholar
• Zelent, A., F. Guidez, A. Melnick, S. Waxman, and J. D. Licht. 2001. Translocations of the RARα gene in acute promyelocytic leukemia. Oncogene 20: 7186–7203.
   PubMed Web of Science ®Google Scholar
• Zhang, D., S. Vuocolo, V. Masciullo, T. Sava, A. Giordano, D. R. Soprano, and K. J. Soprano. 2001. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene 20: 7935–7944.
   PubMed Web of Science ®Google Scholar
• Zhao, X., and R. A. Spanjaard. 2003. The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis. J. Biomed. Sci. 10: 44–49.
   PubMed Web of Science ®Google Scholar